Assuming approach is required, the following results were found.

  • Research on immune activity in MS

    through further research, these basic laboratory studies could eventually be translated to promising new therapeutic approaches to stimulating myelin repair to restore function in people with MS. Read more Treatment with ATX-MS-1467 (Apitope) – an...

    https://mschristian.org/index.php/blog/research-on-immune-activity-in-ms
  • Link between gut flora and multiple sclerosis discovered

    can soon also be translated into therapy; she plans to test the immunoactive components of GDP-L-fucose synthase using an approach that the researchers have been pursuing for several years already. Date: Source: University of Zurich Summary: In...

    https://mschristian.org/index.php/blog/link-between-gut-flora-and-multiple-sclerosis-discovered
  • June Halper Describes the Team-Based Approach Underlying the Consortium of MS Centers

    executive officer, Consortium of Multiple Sclerosis Centers. Click to listen to June Halper as she describes a Team-based approach to care........................................................................................................ This...

    https://mschristian.org/index.php/blog/june-halper-describes-the-team-based-approach-underlying-the-consortium-of-ms-centers
  • Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress - streetinsider.com

    to access https://www.streetinsider.com/Business Wire/Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress/15912284.html from 204.152.211.44 on 2019-09-15 15:50:00 UTC. Trace:...

    https://mschristian.org/index.php/blog/anokion-presents-new-data-describing-transformative-therapeutic-approach-for-treatment-of-multiple-sclerosis-at-ectrims-congress-streetinsider-com
  • New compound offers superior therapeutic approach to treat MS

    increasing the risk of cancer, heart disease and stroke. An interdisciplinary team of scientists have piggy-backed on this approach with a new concept that side steps the negative side effects while alleviating symptoms. In a paper published on January...

    https://mschristian.org/index.php/blog/new-compound-offers-superior-therapeutic-approach-to-treat-ms
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management. By: Aaron Boster, MD Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest...

    https://mschristian.org/index.php/blog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

    September 2019 – Companies plan to seek FDA clearance for digital therapeutics approach – The list of physical symptoms of multiple sclerosis (MS) is long and varied, including fatigue, numb limbs and tremors. But many people living with MS also...

    https://mschristian.org/index.php/blog/sanofi-and-happify-health-solidify-collaboration-around-prescription-dtx-designed-to-address-mental-health-in-people-with-ms
  • Studies Report on Efforts to Optimize Rituximab in MS, NMOSD - The Center for Biosimilars

    optica spectrum disorder (NMOSD) using rituximab.2 In the study, 15 patients with NMOSD were treated using a standard approach, under which rituximab is readministered only once memory B cells reached 0.05% of peripheral blood mononuclear cells, and 29...

    https://mschristian.org/index.php/blog/studies-report-on-efforts-to-optimize-rituximab-in-ms-nmosd-the-center-for-biosimilars
  • Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

    Data being presented at ECTRIMS include positive Phase III results for satralizumab as a monotherapy, taking a novel approach to treating neuromyelitisoptica spectrum disorder, and new insights using biomarkers to identify disease progression in...

    https://mschristian.org/index.php/blog/genentech-to-present-pivotal-data-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-and-six-year-ocrevus-ocrelizumab-data-in-multiple-sclerosis-at-ectrims
  • Central Michigan Hospital plots leadership path in MS research (Blood testing for MS, NeuroFilaments and more)

    tested that will help doctors pinpoint stage of disease and best drug to slow debilitating effects Multi-disciplinary team approach cuts testing and diagnosis process to one day Rany Aburashed, D.O. Neurologist Rany Aburashed, D.O., is leading Memorial...

    https://mschristian.org/index.php/blog/central-michigan-hospital-plots-leadership-path-in-ms-research-blood-testing-for-ms-neurofilaments-and-more
  • Research Project 3TR To Use Breath Biopsy, Improve Immune-mediated Disease Management - Technology Networks

    between longitudinal molecular and microbiome profiles in blood cells and tissues, and disease paths. In a unique approach we will study the seven diseases both in parallel and jointly”, explains Marta Alarcón-Riquelme, scientific coordinator of 3TR....

    https://mschristian.org/index.php/blog/research-project-3tr-to-use-breath-biopsy-improve-immune-mediated-disease-management-technology-networks
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    provides an opportunity to view the biological processes in a way that is not possible on Earth. This innovative approach to modelling disease has the potential to provide valuable new insight into the fundamental mechanisms underlying neurodegenerative...

    https://mschristian.org/index.php/blog/first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire
  • Leading Suicide Prevention Organization and Correctional Health Care Experts Release Suicide Prevention Resource Guide - P&T Community

    consistent, comprehensive training to all involved personnel. The Guide includes suicide risk assessment principles, approaches to intervention and treatment, a training curriculum guide, real-life case studies, and facility design considerations. "We...

    https://mschristian.org/index.php/blog/leading-suicide-prevention-organization-and-correctional-health-care-experts-release-suicide-prevention-resource-guide-p-t-community
  • Potential genetic markers of multiple sclerosis severity

    of MS, an unpredictable disorder in which the immune system eats away at protective insulation around nerve cells. This approach, the researchers say, represents the beginning of precision medicine for MS and may ultimately allow designer therapies, as...

    https://mschristian.org/index.php/blog/potential-genetic-markers-of-multiple-sclerosis-severity
  • Over-the-skin electrical stimulation helps provide movement in quadriplegics - P&T Community

    that regulates individual finger forces to facilitate functional movement in paralyzed individuals. "We developed an approach that accurately controls muscle contractions and resulting forces exerted by the fingers," said Bouton. "This opens up future...

    https://mschristian.org/index.php/blog/over-the-skin-electrical-stimulation-helps-provide-movement-in-quadriplegics-p-t-community
  • Researchers identify genes linked to most severe symptoms of multiple sclerosis

    of MS, an unpredictable disorder in which the immune system eats away at protective insulation around nerve cells. This approach, the researchers say, represents the beginning of precision medicine for MS and may ultimately allow designer therapies, as...

    https://mschristian.org/index.php/blog/researchers-identify-genes-linked-to-most-severe-symptoms-of-multiple-sclerosis
  • New treatment shows promise to reverse celiac disease

    "This makes celiac disease a perfect condition to address using this exciting nanoparticle induced immune tolerance approach." Kelly, who will be presenting the research abstract in Barcelona, has been working with Miller to apply the technology and...

    https://mschristian.org/index.php/blog/new-treatment-shows-promise-to-reverse-celiac-disease
  • icometrix selected as one of the 150 most innovative digital health startups worldwide by CB Insights - PRNewswire

    individual patients with the right treatment at the right moment," Prof. Van Hecke concludes. Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors...

    https://mschristian.org/index.php/blog/icometrix-selected-as-one-of-the-150-most-innovative-digital-health-startups-worldwide-by-cb-insights-prnewswire
  • New immunotherapy targeting blood-clotting protein

    of different etiologies with blood-brain barrier leaks," said Akassoglou. "Targeting fibrin with immunotherapy is a new approach that could be used totest the therapeutic benefits of suppressing this pathogenic mechanism in multiple disease contexts."...

    https://mschristian.org/index.php/blog/new-immunotherapy-targeting-blood-clotting-protein
  • Handling Stress - Mind-Body Basics for People with MS

    diagnosed. Not only has modern medicine improved the treatments available for MS, but there's also a much more holistic approach. “Now doctors tell you that you absolutely should move and do whatever you can to stay active,” says Eisenberg, who lives in...

    https://mschristian.org/index.php/blog/handling-stress-mind-body-basics-for-people-with-ms

Results 1 - 20 of 42
 
 

Follow Us on Twitter

Follow Us On Twitter - Image